摘要
帕金森氏病表述经被改成了“帕金森氏多类疾病”,在一些调查PD存在不同亚型的研究中,其被用来描述从不同临床患者中观察到的表型。PD患者可以根据临床特征分组。只考虑运动症状,可以分为两类:“震颤型”和“运动不便型”,静止震颤、运动不便/运动迟缓和肌僵直分别是二者最主要的特征。非运动症状(NMSs)常常在疾病过程中出现,其中一些症状(便秘、抑郁状态、嗅觉减退和焦虑)甚至在典型的运动症状发作前存在。许多其他的NMSs,尤其是幻觉、认知障碍、睡眠障碍和吞咽困难、在疾病的晚期有极大地影响,当这些症状同时出现,且严重程度不同时,对于治疗是一个真正的挑战。如果没有充分治疗,他们会增加住院治疗的风险和疗养院入院负担,并且极度负面影响着患者们的生活质量和参与社会活动能力。最近联合运动和非运动症状,许多PD亚型被提出。这个分类来源于聚类分析,其根据运动和非运动症状的相关性统计识别不同帕金森患者亚型。在这点上,我们根据聚类症状表现(运动和非运动症状)及使用对PD多类症状起效的药物,提出了一个帕金森氏病的运动和非运动症状的治疗方法示意图。
关键词: 聚类症状,运动症状,非运动症状,帕金森氏病,亚型,治疗
Current Drug Targets
Title:Treatment of the Motor and Non-Motor Symptoms in Parkinson's Disease According to Cluster Symptoms Presentation
Volume: 15 Issue: 10
Author(s): Fulvio Lauretani, Antonio Saginario, Gian Paolo Ceda, Laura Galuppo, Livia Ruffini, Anna Nardelli and Marcello Maggio
Affiliation:
关键词: 聚类症状,运动症状,非运动症状,帕金森氏病,亚型,治疗
摘要: The term Parkinson’s disease has been changed in ‘Parkinson's diseases’ to describe different clinical entities observed in several studies investigating the existence of PD subtypes. PD patients could be grouped based on clinical features. By considering only motor symptoms, we can classically distinguish two groups: “ the tremorigen-form” and “akinetic- rigidity-form” where resting tremor and akinesia/bradikynesia and rigidity are the most motor predominant symptoms, respectively. Non-motor symptoms (NMSs) are practically always present during the course of the disease and some of them (constipation, depressive status, hyposmia and anxiety) could even exist before the onset of classical motor symptoms. Many other NMSs and in particular hallucinations, cognitive impairment, sleep disorders and difficulty in swallowing strongly affect the advanced stage of disease, and represent a real therapeutic challenge when these symptoms are simultaneously present with different severity. If not adequately treated, they can increase the risk of hospitalization and admissions in nursing home, and profoundly and negatively influence the quality of life and participation in social activity of these patients. PD subtypes according to the combination of motor and non-motor symptoms have been recently proposed. This classification derives from cluster analysis which permits to identify statistically distinct subtypes of Parkinsonian patients according to the relevance of both motor and non-motor symptoms. In this point of view, we propose a schematic therapeutic approach of motor and non-motor symptoms in Parkinson’s disease according to cluster symptoms presentation (motor and non-motor symptoms) and using medications that act on multiple domains of PD symptoms.
Export Options
About this article
Cite this article as:
Lauretani Fulvio, Saginario Antonio, Ceda Paolo Gian, Galuppo Laura, Ruffini Livia, Nardelli Anna and Maggio Marcello, Treatment of the Motor and Non-Motor Symptoms in Parkinson's Disease According to Cluster Symptoms Presentation, Current Drug Targets 2014; 15 (10) . https://dx.doi.org/10.2174/1389450115666140826104030
DOI https://dx.doi.org/10.2174/1389450115666140826104030 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Patents on Morphometric Analysis of Eukaryotic Cells
Recent Patents on Medical Imaging Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
CNS & Neurological Disorders - Drug Targets The Role of Tai Chi in Mental Health Management—Lessons Learned from Clinical Trials
Reviews on Recent Clinical Trials The Capsaicin Paradox: Pain Relief by an Algesic Agent
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial: [Exciting Discoveries About New p53 Target Genes, Cancer Drugs and Diagnostic Tools, and Mechanisms of Various Human Diseases]
Current Molecular Medicine Pantothenate Kinase-Associated Neurodegeneration
Current Drug Targets Dysfunctional Voiding in Pediatrics: A Review of Pathophysiology and Current Treatment Modalities
Current Pediatric Reviews Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Electrotransfer into Skeletal Muscle for Protein Expression
Current Gene Therapy 20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
Current Drug Discovery Technologies Food-Derived Peptides and Intestinal Functions
Current Pharmaceutical Design Small and Hungry: MicroRNAs in Micronutrient Homeostasis of Plants
MicroRNA Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component
Current Pharmaceutical Design Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design Molecular Imaging: Its Application In Cardiovascular Diagnosis
Current Pharmaceutical Design The Role of Protonation States in Ligand-Receptor Recognition and Binding
Current Pharmaceutical Design Phenylbutyric Acid: Simple Structure - Multiple Effects
Current Pharmaceutical Design Biotechnological Approaches for the Treatment of Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Transmucosal Drug Delivery- An Overview
Drug Delivery Letters Solution NMR Studies of Aβ Monomer Dynamics
Protein & Peptide Letters